Bacterial Meningitis in the United States, 1998–2007

Michael C. Thigpen, Cynthia G. Whitney, Nancy E. Messonnier, Elizabeth R. Zell, Ruth Lynfield(Minnesota Department of Health), James L. Hadler(Connecticut Department of Public Health), Lee H. Harrison(Johns Hopkins University), Monica M. Farley(Georgia Department of Natural Resources), Arthur Reingold, Nancy M. Bennett(University of Rochester), Allen S. Craig(Vanderbilt University), William Schaffner(Vanderbilt University), Ann Thomas(Oregon Health Authority), Melissa Lewis, Elaine Scallan, Anne Schuchat
New England Journal of Medicine
May 25, 2011
Cited by 949Open Access
Full Text

Abstract

The rate of bacterial meningitis declined by 55% in the United States in the early 1990s, when the Haemophilus influenzae type b (Hib) conjugate vaccine for infants was introduced. More recent prevention measures such as the pneumococcal conjugate vaccine and universal screening of pregnant women for group B streptococcus (GBS) have further changed the epidemiology of bacterial meningitis.


Related Papers

No related papers found

Powered by citation graph analysis